MVA-SARS-2-S

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMVA-SARS-2-S

Drug Alias NameMVA-SARS-2-ST

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesUniversitätsklinikum Hamburg-Eppendorf

China Registration ClassN/A

Develop Information

Active CompaniesUniversitätsklinikum Hamburg-Eppendorf

Inactive CompaniesHannover Medical School

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A